“In Korea, they have over 70 neurotoxin competitors,” Kim said. “Botox is considered a very good product there, but the problem is it’s expensive. So Letybo, or Botulax, is viewed as a great product — ...

Before Letybo was approved, there were five neuromodulators available to injectors in the US: Botox, Xeomin, Dysport, Daxxify ...